Ethambutol & INH
Ethambutol is an antimycobacterial medication used in the treatment of tuberculosis (TB). It works by inhibiting the formation of the cell wall in Mycobacterium tuberculosis, the bacteria responsible for TB.Ethambutol is primarily indicated for the treatment of tuberculosis, either alone or in combination with other antitubercular drugs.
The typical dosage of ethambutol for adults is usually 15-25 mg/kg body weight per day, administered orally. The dosage may vary based on the specific treatment regimen prescribed by a healthcare professional.
Ethambutol is contraindicated in individuals with known hypersensitivity to the drug. Caution should be exercised in patients with optic neuritis or impaired renal function.
-Regular monitoring of visual acuity and color vision is essential during ethambutol therapy. -Ethambutol should be used with caution in patients with renal impairment, and dosage adjustments may be necessary.
Common side effects of ethambutol include optic neuritis, which may result in vision changes, as well as gastrointestinal disturbances, rash, and joint pain.
Ethambutol may interact with certain antacids, reducing its absorption. It is important to separate the administration of ethambutol and antacids by at least 4 hours.
Brand Name | Manufactured by |
---|---|
CAVIBUTOL-H | MERIND LIMITED |
COMBUNEX | LUPIN LTD. |
INABUTOL FORTE | THEMIS CHEMICALS |
MARCONEX | MARC LABORATORIES PVT. LTD |
MYCONEX | LE SANTE |
THEMIBUTOL PLUS | THEMIS |